Table I.
Patients' characteristics.
| Variable | No. of patients | Percentage, % |
|---|---|---|
| Median age (years) | 44 (range, 26-79) | |
| Median duration (months) | 3.66 (range, 1.40-5.62) | |
| Subtype | ||
| HR+ | 42 | 54.55 |
| HER2+ | 7 | 9.09 |
| TN | 28 | 36.36 |
| Metastases | ||
| Liver | 15 | 19.48 |
| Lung | 20 | 25.97 |
| Bone | 24 | 31.17 |
| Brain | 5 | 6.49 |
| Lymph nodes | 29 | 37.66 |
| Response | ||
| CR | 3 | 3.90 |
| PR | 21 | 27.27 |
| SD | 26 | 33.77 |
| PD | 27 | 35.06 |
| ORR | 24 | 31.17 |
| DCR | 50 | 64.94 |
HR, hormone receptor; HER2, human epidermal growth factor receptor 2; TN, triple-negative; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; ORR, objective response rate; DCR, disease control rate.